Precise assessment of dystonia severity is essential for effective treatment and drug development, but current evaluation methods, such as BFM, TWSTRS and CDIP-58, rely heavily on subjective scales. These tools highlight the need for more objective and efficient evaluation methods.
Various technologies have been investigated to achieve objective assessments, although these methods offer accuracy, they are time-intensive and may influence symptoms, as physical contact can alter dystonia manifestations.
X-linked dystonia-parkinsonism (XDP) presents with a mix of dystonic and parkinsonian symptoms that progress and regress over time, making it vital to monitor the disease’s course accurately.